» Articles » PMID: 10330134

Dimeric RFX Proteins Contribute to the Activity and Lineage Specificity of the Interleukin-5 Receptor Alpha Promoter Through Activation and Repression Domains

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1999 May 18
PMID 10330134
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-5 (IL-5) plays a central role in the differentiation, proliferation, and functional activation of eosinophils. The specific action of IL-5 on eosinophils and hematopoietically related basophils is regulated by the restricted expression of IL-5 receptor alpha (IL-5Ralpha), a subunit of high-affinity IL-5R, on these cells. We have previously identified an enhancer-like cis element in the IL-5Ralpha promoter that is important for both full promoter function and lineage-specific activity. Here, we demonstrate by yeast one-hybrid screening that RFX2 protein specifically binds to this cis element. RFX2 belongs to the RFX DNA-binding protein family, the biological role of which remains obscure. Using an electrophoretic mobility shift assay, we further show that RFX1, RFX2, and RFX3 homodimers and heterodimers specifically bind to the cis element of the IL-5Ralpha promoter. The mRNA expression of RFX1, RFX2, and RFX3 was detected ubiquitously, but in transient-transfection assays, multimerized RFX binding sites in front of a basal promoter efficiently functioned in a tissue- and lineage-specific manner. To further investigate RFX functions on transcription, full-length and deletion mutants of RFX1 were targeted to DNA through fusion to the GAL4 DNA binding domain. Tissue- and lineage-specific transcriptional activation with the full-length RFX1 fusion plasmid on a reporter controlled by GAL4 binding sites was observed. Distinct activation and repression domains within the RFX1 protein were further mapped. Our findings suggest that RFX proteins are transcription factors that contribute to the activity and lineage specificity of the IL-5Ralpha promoter by directly binding to a target cis element and cooperating with other tissue- and lineage-specific cofactors.

Citing Articles

PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression.

Schmidt C, Cohen S, Gudenas B, Husain S, Carlson A, Westelman S Sci Rep. 2024; 14(1):16074.

PMID: 38992221 PMC: 11239875. DOI: 10.1038/s41598-024-66811-6.


Reverse Engineering of the Pediatric Sepsis Regulatory Network and Identification of Master Regulators.

Oliveira R, Imparato D, Fernandes V, Cavalcante J, DOliveira Albanus R, Dalmolin R Biomedicines. 2021; 9(10).

PMID: 34680414 PMC: 8533457. DOI: 10.3390/biomedicines9101297.


Transcriptional Regulation of the Human IL5RA Gene through Alternative Promoter Usage during Eosinophil Development.

Laffey K, Du J, Schrum A, Ackerman S Int J Mol Sci. 2021; 22(19).

PMID: 34638583 PMC: 8549700. DOI: 10.3390/ijms221910245.


RFX1: a promising therapeutic arsenal against cancer.

Issac J, Raveendran P, Das A Cancer Cell Int. 2021; 21(1):253.

PMID: 33964962 PMC: 8106159. DOI: 10.1186/s12935-021-01952-6.


T cell reactivity to regulatory factor X4 in type 1 narcolepsy.

Luo G, Yogeshwar S, Lin L, Mignot E Sci Rep. 2021; 11(1):7841.

PMID: 33837283 PMC: 8035403. DOI: 10.1038/s41598-021-87481-8.


References
1.
Radomska H, Huettner C, Zhang P, Cheng T, Scadden D, Tenen D . CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol. 1998; 18(7):4301-14. PMC: 109014. DOI: 10.1128/MCB.18.7.4301. View

2.
Yamaguchi Y, Ackerman S, Minegishi N, Takiguchi M, Yamamoto M, Suda T . Mechanisms of transcription in eosinophils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule major basic protein gene. Blood. 1998; 91(9):3447-58. View

3.
Baltus B, van Dijk T, Caldenhoven E, Zanders E, Raaijmakers J, Lammers J . An AP-1 site in the promoter of the human IL-5R alpha gene is necessary for promoter activity in eosinophilic HL60 cells. FEBS Lett. 1998; 434(3):251-4. DOI: 10.1016/s0014-5793(98)00991-0. View

4.
Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

5.
Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View